Medistim ASA (STU:MD1) Beneish M-Score: -2.45 (As of Jun. 26, 2026)


STU:MD1 Medistim ASA STU:MD1
92 GF Score
Price €20.10
GF Value €22.94
! 1 Warning Sign
View Full Analysis

What is Medistim ASA Beneish M-Score?

Medistim ASA STU:MD1 +1.00% 92 Beneish M-Score is -2.45 as of Jun. 26, 2026. GuruFocus rates STU:MD1 with a GF Score™ of 92/100 and a GF Value™ of €22.94. The stock has 1 warning sign investors should review. Among 766 Medical Devices & Instruments companies, Medistim ASA ranks worse than 61.75% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.45 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Medistim ASA's Beneish M-Score or its related term are showing as below:

STU:MD1' s Beneish M-Score Range Over the Past 10 Years
Min: -2.88   Med: -2.48   Max: -2.13
Current: -2.45

During the past 13 years, the highest Beneish M-Score of Medistim ASA was -2.13. The lowest was -2.88. And the median was -2.48.


Medistim ASA Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Medistim ASA's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA Beneish M-Score Chart

Medistim ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.69 -2.13 -2.74 -2.75 -2.45

Medistim ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.45 0.00

STU:MD1 vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Medistim ASA's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Beneish M-Score falls into.


STU:MD1
92GF Score
Medistim ASA STU:MD1
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medistim ASA Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medistim ASA for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9615+0.528 * 0.9769+0.404 * 1.2164+0.892 * 1.2348+0.115 * 1.052
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8279+4.679 * -0.04219-0.327 * 1.1889
=-2.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was €7.89 Mil.
Revenue was €59.13 Mil.
Gross Profit was €48.30 Mil.
Total Current Assets was €40.37 Mil.
Total Assets was €55.82 Mil.
Property, Plant and Equipment(Net PPE) was €6.71 Mil.
Depreciation, Depletion and Amortization(DDA) was €1.35 Mil.
Selling, General, & Admin. Expense(SGA) was €5.27 Mil.
Total Current Liabilities was €12.10 Mil.
Long-Term Debt & Capital Lease Obligation was €3.18 Mil.
Net Income was €13.45 Mil.
Gross Profit was €0.00 Mil.
Cash Flow from Operations was €15.81 Mil.
Total Receivables was €6.64 Mil.
Revenue was €47.88 Mil.
Gross Profit was €38.21 Mil.
Total Current Assets was €36.53 Mil.
Total Assets was €48.94 Mil.
Property, Plant and Equipment(Net PPE) was €6.11 Mil.
Depreciation, Depletion and Amortization(DDA) was €1.31 Mil.
Selling, General, & Admin. Expense(SGA) was €5.15 Mil.
Total Current Liabilities was €9.14 Mil.
Long-Term Debt & Capital Lease Obligation was €2.13 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(7.886 / 59.128) / (6.642 / 47.884)
=0.133372 / 0.13871
=0.9615

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(38.209 / 47.884) / (48.298 / 59.128)
=0.797949 / 0.816838
=0.9769

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (40.366 + 6.708) / 55.819) / (1 - (36.525 + 6.109) / 48.937)
=0.156667 / 0.128798
=1.2164

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=59.128 / 47.884
=1.2348

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.31 / (1.31 + 6.109)) / (1.353 / (1.353 + 6.708))
=0.176574 / 0.167845
=1.052

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(5.269 / 59.128) / (5.154 / 47.884)
=0.089112 / 0.107635
=0.8279

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3.184 + 12.101) / 55.819) / ((2.133 + 9.138) / 48.937)
=0.273831 / 0.230317
=1.1889

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(13.453 - 0 - 15.808) / 55.819
=-0.04219

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medistim ASA has a M-score of -2.45 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.45 mean?
Medistim ASA (STU:MD1) has a Beneish M-Score of -2.45 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medistim ASA and its competitors. According to the industry distribution chart, Medistim ASA ranks #473 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 61.7%.
Is Medistim ASA's Beneish M-Score too high?
Medistim ASA's current Beneish M-Score is -2.45. Based on the distribution chart, Medistim ASA ranks #473 out of 766 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medistim ASA has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medistim ASA ranks #473 out of 766 companies for Beneish M-Score. This places Medistim ASA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medistim ASA and its competitors. Medistim ASA's current Beneish M-Score is -2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Medistim ASA (STU:MD1) has a current Beneish M-Score of -2.45. The stock's GF Value™ is €22.94, compared to a current price of €20.10 — trading 12.4% below its estimated fair value. The current Beneish M-Score is -2.45. Medistim ASA's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Medistim ASA (STU:MD1), the current Beneish M-Score is -2.45 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medistim ASA (STU:MD1) Overvalued in 2026?

Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued. The current stock price of €20.10 is trading 12.4% below its estimated GF Value™ of €22.94.

Key valuation signals for STU:MD1:

  • Beneish M-Score: -2.45
  • GF Value™: €22.94 vs. price of €20.10 (12.4% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the STU:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medistim ASA Business Description

Address Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
92GF Score

Get the complete analysis for STU:MD1

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.10
Price
€22.94
GF Value